Celebrating remarkable progress: Queen’s Anniversary Prize recognises vital contribution

Tiny Targets, developed by Vestergaard and Liverpool School of Tropical Medicine, drastically reduced sleeping sickness, earning the Queen’s Anniversary Prize for impactful innovation.


Innovation, Collaboration…Elimination

How innovative vector control solutions like Tiny Targets and close academia – industry partnerships will support the eradication of sleeping sickness


On the brink of the elimination of sleeping sickness

In this Q&A, Joseph Ndung’u will address questions related to the progress on the elimination of sleeping sickness and the Trypa-NO! partnership.


Thank you for signing up for our newsletter